Eye contact: Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Remove contact lenses, if present, after 5 minutes, then continue rinsing eye. Call a POISON CENTRE or doctor/physician.
Revlimid is a medicine used for the treatment of multiple myeloma, myelodysplastic syndromes and mantle cell lymphoma, which are conditions affecting blood cells and bone marrow. In multiple myeloma, a cancer of a type of white blood cells called plasma cells, Revlimid is used:
REVLIMIDÂ®, a potent immunomodulatory derivative (IMiD) of thalidomide, induces apoptosis [programmed cell death] in resistant MM cell lines and patient cells and, more importantly, decreases binding of MM cells to bone marrow stromal cells.